Epidemiology of Parkinson's disease, The Lancet Neurology, vol.5, issue.6, pp.525-535, 2006. ,
DOI : 10.1016/S1474-4422(06)70471-9
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, The Lancet Neurology, vol.8, issue.12, pp.1128-1139, 2009. ,
DOI : 10.1016/S1474-4422(09)70293-5
Levodopa: the story so far, Nature, vol.466, issue.7310, pp.6-7, 2010. ,
DOI : 10.1038/466S6a
Neurovascular mechanisms and blood???brain barrier disorder in Alzheimer???s disease, Acta Neuropathologica, vol.6, issue.1, pp.103-113, 2009. ,
DOI : 10.1007/s00401-009-0522-3
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia, Acta Neuropathologica, vol.57, issue.3, pp.287-296, 2010. ,
DOI : 10.1007/s00401-010-0718-6
Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson's disease, Clinical Neurology and Neurosurgery, vol.113, issue.10, pp.830-834, 2011. ,
DOI : 10.1016/j.clineuro.2011.05.014
Parkinson disease and comorbid cerebrovascular disease, Nature Reviews Neurology, vol.255, issue.10, pp.533-541, 2009. ,
DOI : 10.1038/nrneurol.2009.136
Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI, NeuroImage, vol.59, issue.3, pp.2743-2750, 2012. ,
DOI : 10.1016/j.neuroimage.2011.10.033
Endothelial Proliferation and Increased Blood-Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-L-Alanine-Induced Dyskinesia, Journal of Neuroscience, vol.26, issue.37, pp.9448-9461, 2006. ,
DOI : 10.1523/JNEUROSCI.0944-06.2006
Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling, NeuroImage, vol.30, issue.3, pp.700-712, 2006. ,
DOI : 10.1016/j.neuroimage.2005.10.029
Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease, Neuropsychopharmacology, vol.279, issue.12, pp.2477-2488, 2009. ,
DOI : 10.1016/S0008-6363(00)00268-6
Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review, Movement Disorders, vol.19, issue.2 suppl, pp.149-156, 2010. ,
DOI : 10.1002/mds.22937
Perivascular nerves in brain vessels, Cerebral Blood Flow and Metabolism, 2002. ,
Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure, Journal of the Neurological Sciences, vol.243, issue.1-2, pp.57-60, 2006. ,
DOI : 10.1016/j.jns.2005.11.028
Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler study, Journal of the Neurological Sciences, vol.254, issue.1-2, pp.49-53, 2007. ,
DOI : 10.1016/j.jns.2006.12.017
Evaluation of cerebral vasomotor reactivity in Parkinson's disease: Is there any association with orthostatic hypotension?, Clinical Neurology and Neurosurgery, vol.113, issue.5, pp.368-372, 2011. ,
DOI : 10.1016/j.clineuro.2010.12.014
Brain Mapping: From Neural Basis of Cognition to Surgical Applications Vienna, pp.45-59 ,
Impaired fMRI activation in patients with primary brain tumors, NeuroImage, vol.52, issue.2, pp.538-548, 2010. ,
DOI : 10.1016/j.neuroimage.2010.04.194
URL : https://hal.archives-ouvertes.fr/inserm-00497736
Regional Impairment of Cerebrovascular Reactivity and BOLD Signal in Adults After Stroke, Stroke, vol.36, issue.6, pp.1146-1152, 2005. ,
DOI : 10.1161/01.STR.0000166178.40973.a7
URL : https://hal.archives-ouvertes.fr/inserm-00391163
The influence of extra- and intracranial artery disease on the BOLD signal in FMRI, NeuroImage, vol.20, issue.2, pp.1393-1399, 2003. ,
DOI : 10.1016/S1053-8119(03)00384-7
Impact of Extracranial-Intracranial Bypass on Cerebrovascular Reactivity and Clinical Outcome in Patients With Symptomatic Moyamoya Vasculopathy, Stroke, vol.42, issue.11, pp.3047-3054, 2011. ,
DOI : 10.1161/STROKEAHA.111.615955
Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI, NeuroImage, vol.58, issue.2, pp.579-587, 2011. ,
DOI : 10.1016/j.neuroimage.2011.06.070
Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease, Neurobiology of Aging, vol.33, issue.1, pp.75-82, 2012. ,
DOI : 10.1016/j.neurobiolaging.2010.02.005
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease., Journal of Neurology, Neurosurgery & Psychiatry, vol.51, issue.6, pp.745-752, 1988. ,
DOI : 10.1136/jnnp.51.6.745
The assessment and analysis of handedness: The Edinburgh inventory, Neuropsychologia, vol.9, issue.1, pp.97-113, 1971. ,
DOI : 10.1016/0028-3932(71)90067-4
Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis, Movement Disorders, vol.47, issue.Pt 1, pp.630-640, 2004. ,
DOI : 10.1002/mds.20083
Mapping Cerebrovascular Reactivity Using Blood Oxygen Level-Dependent MRI in Patients With Arterial Steno-occlusive Disease: Comparison With Arterial Spin Labeling MRI, Stroke, vol.39, issue.7, pp.2021-2028, 2008. ,
DOI : 10.1161/STROKEAHA.107.506709
Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease, Journal of Neuroscience, vol.28, issue.16, pp.4201-4209, 2008. ,
DOI : 10.1523/JNEUROSCI.0582-08.2008
Effect of Basal Conditions on the Magnitude and Dynamics of the Blood Oxygenation Level???Dependent fMRI Response, Journal of Cerebral Blood Flow & Metabolism, vol.14, pp.1042-1053, 2002. ,
DOI : 10.1097/00004647-200209000-00002
The effect of global cerebral vasodilation on focal activation hemodynamics, NeuroImage, vol.30, issue.3, pp.726-734, 2006. ,
DOI : 10.1016/j.neuroimage.2005.10.038
URL : https://hal.archives-ouvertes.fr/inserm-00388982
Pharmacologically modulated fMRI---cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients, Brain, vol.126, issue.2, pp.451-461, 2003. ,
DOI : 10.1093/brain/awg033
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa, Brain, vol.124, issue.3, pp.558-570, 2001. ,
DOI : 10.1093/brain/124.3.558
Focusing effects of L-dopa in Parkinson's disease, Human Brain Mapping, vol.32, issue.Part 2, pp.88-97, 2010. ,
DOI : 10.1002/hbm.20847
The subacute levodopa test for evaluating long-duration response in parkinson's disease, Annals of Neurology, vol.66, issue.3, pp.389-395, 1995. ,
DOI : 10.1002/ana.410380308
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease, Brain Research Bulletin, vol.74, issue.1-3, pp.75-83, 2007. ,
DOI : 10.1016/j.brainresbull.2007.05.009